Pharmacokinetic (PK) and pharmacodynamics (PD) properties of SC-PEG e. coli L-asparaginase (EZN-2285) in the treatment of patients with acute lymphoblastic leukemia ( ALL): Results from Children's Oncology Group (COG) study AALL07P4.

被引：0
|
作者：
Angiolillo, Anne L.
Schore, Reuven J.
Reaman, Gregory H.
Winick, Naomi Joan
Devidas, Meenakshi
Zheng, Hao W.
Wood, Charlotte
Lane, Ashley R.
Raetz, Elizabeth A.
Carroll, William L.
Hunger, Stephen
机构：
[1] Childrens Natl Med Ctr, Washington, DC 20010 USA
[2] UTSW, Dallas, TX USA
[3] Childrens Med Ctr, Ctr Canc & Blood Disorders, Dallas, TX 75235 USA
[4] Childrens Oncol Grp, Gainesville, FL USA
[5] NYU, Langone Med Ctr, New York, NY USA
[6] Univ Colorado, Denver Hlth Sci Ctr, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9543
引用
收藏
页数：1
相关论文
共 6 条
  • [1] Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4
    Angiolillo, Anne L.
    Schore, Reuven J.
    Devidas, Meenakshi
    Borowitz, Michael J.
    Carroll, Andrew J.
    Gastier-Foster, Julie M.
    Heerema, Nyla A.
    Keilani, Taha
    Lane, Ashley R.
    Loh, Mignon L.
    Reaman, Gregory H.
    Adamson, Peter C.
    Wood, Brent
    Wood, Charlotte
    Zheng, Hao W.
    Raetz, Elizabeth A.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (34) : 3874 - U276
  • [2] Plasma asparaginase activity and asparagine depletion in patients with acute lymphoblastic leukemia (ALL) treated with pegaspargase (SS-PEG E. coli L-asparaginase): Results from Children's Oncology Group (COG) study AALLO7P4.
    Schore, Reuven J.
    Devidas, Meenakshi
    Bleyer, Archie
    Reaman, Gregory H.
    Winick, Naomi J.
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Carroll, William L.
    Hunger, Stephen
    Angiolillo, Anne L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG).
    Salzer, Wanda
    Asselin, Barbara
    Supko, Jeffrey
    Devidas, Meenakshi
    Kaiser, Nicole
    Plourde, Paul V.
    Winick, Naomi
    Reaman, Gregory
    Raetz, Elizabeth
    Carroll, William L.
    Hunger, Stephen
    BLOOD, 2010, 116 (21) : 882 - 882
  • [4] Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children's Oncology Group (COG) Study AALL0331
    Mattano, Leonard A.
    Devidas, Meenakshi
    Friedmann, Alison M.
    Raetz, Elizabeth A.
    Loh, Mignon
    Buckley, Patrick
    Borowitz, Michael J.
    Carroll, Andrew J.
    Gastier-Foster, Julie
    Heerema, Nyla A.
    Kadan-Lottick, Nina
    Matloub, Yousif
    Marshall, David T.
    Stork, Linda C.
    Wood, Brent L.
    Winick, Naomi J.
    Hunger, Stephen
    Carroll, William L.
    Maloney, Kelly
    BLOOD, 2014, 124 (21)
  • [5] A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1
    Guest, Erin
    Kairalla, John
    Devidas, Meenakshi
    Hibbitts, Emily
    Carroll, Andrew J.
    Heerema, Nyla A.
    Kubaney, Holly
    August, Amanda
    Pauly, Melinda
    Wechsler, Daniel
    Miles, Rodney R.
    Reid, Joel M.
    Kihei, Cynthia
    Gore, Lia
    Raetz, Elizabeth A.
    Hunger, Stephen P.
    Loh, Mignon L.
    Brown, Patrick A.
    BLOOD, 2022, 140 : 3256 - 3257
  • [6] Anti-Pegaspargase, Anti-Calaspargase Pegol, and Anti-Polyethelene Glycol Antibody Incidence in High Risk Acute Lymphoblastic Leukemia Patients Receiving Pegaspargase or Calaspargase Pegol and Associated Anaphylactic or Hypersensitivity Reaction Rates: Results from Children's Oncology Group (COG) Study AALL07P4
    Schore, Reuven J.
    Devidas, Meenakshi
    Bleyer, Archie
    Reaman, Gregory
    Lebedinsky, Claudia
    Zhang, Hui
    Koppensteiner, Herwig
    Loh, Mignon L.
    Raetz, Elizabeth
    Winick, Naomi
    Carroll, William L.
    Hunger, Stephen P.
    Angiolillo, Anne
    BLOOD, 2016, 128 (22)
1